Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Corace

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Canadian Liver Journal|August 22, 2022
Hepatitis C patient communication source and modality preferences in the direct-acting antiviral eraJulie Beaulac, Kim Corace, Louise Balfour, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 25, 2025
Lived Experience and the Need for Co-Leadership in Mental and Substance Use Health CareTanisse Epp, Kim Hellemans, Kim Corace, et al.
Psychiatry Research. Neuroimaging|February 12, 2022
Resting State EEG Activity Related to Impulsivity in People with Prescription Opioid Use DisorderKim Corace, Renee Baysarowich, Melanie Willows, et al.
Experimental and Clinical Psychopharmacology|January 2, 2025
A pilot study on craving and its relationship to self-ratings of depression and anxiety in prescription opioid use disorderVerner Knott, Renee Baysarowich, Kim Corace, et al.
Frontiers in Public Health|July 12, 2021
Psychological and Demographic Determinants of Substance Use and Mental Health During the COVID-19 PandemicFatima Mougharbel, Hugues Sampasa-Kanyinga, Brandon Heidinger, et al.
The Diabetes Educator|August 7, 2015
Comment on Pladevall et al, "A Randomized Controlled Trial to Provide Adherence Information and Motivational Interviewing to Improve Diabetes and Lipid Control"Tavis S Campbell, Simon L Bacon, Kim Corace, et al.
The International Journal on Drug Policy|February 5, 2022
Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients' and prescribers' experiences with changes in unsupervised dosingKim Corace, Kelly Suschinsky, Jennifer Wyman, et al.
BMC Public Health|April 26, 2023
From design to action: participatory approach to capacity building needs for local overdose response plansMaryam Mallakin, Christina Dery, Yordanos Woldemariam, et al.
BMJ Open|January 12, 2026
Research on Eating and Adolescent Lifestyle (REAL) 2.0: 15-year follow-up study of eating disorders and weight-related trajectories, mental health and substance use health from early adolescence to early adulthood-a Canadian cohort profileNicole Obeid, Annick Buchholz, Abigail Hm Bradley, et al.
The International Journal on Drug Policy|March 30, 2024
Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic reviewCayley Russell, Jenna Ashley, Farihah Ali, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Canadian Liver Journal|August 22, 2022
Hepatitis C patient communication source and modality preferences in the direct-acting antiviral eraJulie Beaulac, Kim Corace, Louise Balfour, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 25, 2025
Lived Experience and the Need for Co-Leadership in Mental and Substance Use Health CareTanisse Epp, Kim Hellemans, Kim Corace, et al.
Psychiatry Research. Neuroimaging|February 12, 2022
Resting State EEG Activity Related to Impulsivity in People with Prescription Opioid Use DisorderKim Corace, Renee Baysarowich, Melanie Willows, et al.
Experimental and Clinical Psychopharmacology|January 2, 2025
A pilot study on craving and its relationship to self-ratings of depression and anxiety in prescription opioid use disorderVerner Knott, Renee Baysarowich, Kim Corace, et al.
Frontiers in Public Health|July 12, 2021
Psychological and Demographic Determinants of Substance Use and Mental Health During the COVID-19 PandemicFatima Mougharbel, Hugues Sampasa-Kanyinga, Brandon Heidinger, et al.
The Diabetes Educator|August 7, 2015
Comment on Pladevall et al, "A Randomized Controlled Trial to Provide Adherence Information and Motivational Interviewing to Improve Diabetes and Lipid Control"Tavis S Campbell, Simon L Bacon, Kim Corace, et al.
The International Journal on Drug Policy|February 5, 2022
Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients' and prescribers' experiences with changes in unsupervised dosingKim Corace, Kelly Suschinsky, Jennifer Wyman, et al.
BMC Public Health|April 26, 2023
From design to action: participatory approach to capacity building needs for local overdose response plansMaryam Mallakin, Christina Dery, Yordanos Woldemariam, et al.
BMJ Open|January 12, 2026
Research on Eating and Adolescent Lifestyle (REAL) 2.0: 15-year follow-up study of eating disorders and weight-related trajectories, mental health and substance use health from early adolescence to early adulthood-a Canadian cohort profileNicole Obeid, Annick Buchholz, Abigail Hm Bradley, et al.
The International Journal on Drug Policy|March 30, 2024
Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic reviewCayley Russell, Jenna Ashley, Farihah Ali, et al.
Pageof 4